Second line treatment with 5-fluorouracil and folonic acid in gemcitabine-pretreated advanced pancreatic cancer

被引：0
|
作者：
Kheira, Rekai [1 ]
Larbaoui, Blaha [2 ]
机构：
[1] EHSO Emir Abdelkader, Med Oncol, Oran, Algeria
[2] CAC Oran, Oran, Algeria
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-195
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study
    Tsavaris, N
    Kosmas, C
    Skopelitis, H
    Gouveris, P
    Kopteridis, P
    Loukeris, D
    Sigala, F
    Zorbala-Sypsa, A
    Felekouras, E
    Papalambros, E
    [J]. INVESTIGATIONAL NEW DRUGS, 2005, 23 (04) : 369 - 375
  • [2] Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study
    Nicolas Tsavaris
    Christos Kosmas
    Helias Skopelitis
    Panagiotis Gouveris
    Petros Kopteridis
    Dioynissis Loukeris
    Frantzeska Sigala
    Alexandra Zorbala-Sypsa
    Evangelos Felekouras
    Efstathios Papalambros
    [J]. Investigational New Drugs, 2005, 23 : 369 - 375
  • [3] Oxaliplatin plus 5-fluorouracil and folinic acid (off) in gemcitabine-pretreated advanced pancreatic cancer: A phase ii study
    El-Hadaad H.A.
    Wahba H.A.
    [J]. Journal of Gastrointestinal Cancer, 2013, 44 (3) : 313 - 317
  • [4] Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer
    Altwegg, Romain
    Ychou, Marc
    Guillaumon, Vanessa
    Thezenas, Simon
    Senesse, Pierre
    Flori, Nicolas
    Mazard, Thibault
    Caillo, Ludovic
    Faure, Stephanie
    Samalin, Emmanuelle
    Assenat, Eric
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (12) : 1357 - 1364
  • [5] Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer
    Boeck, Stefan
    Heinemann, Volker
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1178 - 1179
  • [6] Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer
    Romain Altwegg
    Marc Ychou
    Vanessa Guillaumon
    Simon Thezenas
    Pierre Senesse
    Nicolas Flori
    Thibault Mazard
    Ludovic Caillo
    Stéphanie Faure
    Emmanuelle Samalin
    Eric Assenat
    [J]. World Journal of Gastroenterology, 2012, (12) : 1357 - 1364
  • [7] Second-line treatment with a combination of 5-fluorouracil, adriamycin, and mitomycin-C (FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer
    Lee, S.
    Oh, S.
    Kim, B.
    Kwon, H.
    Kim, S.
    Rho, M.
    Kim, Y.
    Rho, M.
    Kim, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study (vol 23, pg 369, 2005)
    Tsavaris, N
    [J]. INVESTIGATIONAL NEW DRUGS, 2005, 23 (06) : 603 - 603
  • [9] Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer - Reply
    Kulke, Matthew H.
    Fuchs, Charles S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1179 - 1179
  • [10] What Else in Gemcitabine-Pretreated Advanced Pancreatic Cancer? An Update of Second Line Therapies
    Petrelli, Fausto
    Borgonovo, Karen
    Ghilardi, Mara
    Cabiddu, Mary
    Barni, Sandro
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2010, 5 (01) : 43 - 56
12345